National Guideline Clearinghouse | Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.
National Institute for Health and Care Excellence (NICE)
Guideline Title
Dimethyl fumarate for treating relapsing-remitting multiple sclerosis.
Bibliographic Source(s)
| National Institute for Health and Care Excellence. Dimethyl fumarate for treating relapsing-remitting multiple sclerosis. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Aug. 61 p. (Technology appraisal guidance; no. 320). |
Guideline Status
This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.
No hay comentarios:
Publicar un comentario